NEOX®FLO Wound Matrix
NEOX®FLO Wound Matrix is a sterile, particulate human placental tissue product. Used for the management of non-healing and chronic wounds.
• Contains high levels of key proteins, cytokines and growth factors to reduce inflammation, promote healing and regeneration of tissue
NEOX®FLO Wound Matrix is used in the treatment of chronic and acute partial- and full-thickness wounds including: diabetic foot ulcers, venous leg ulcers, arterial ulcers, and pressure ulcers.
Do not use on infected wounds.
As with the use of any human tissue, the possibility of infection agent transmission cannot be completely eliminated although all screening and microbial testing results were satisfactory.
Shelf life is two years from date of manufacture at ambient room temperature. It is the responsibility of the tissue dispensing service, tissue distribution intermediary, and/or end-user clinician to maintain tissue intended for transplantation in appropriate storage.
|Shelf life greater than 2 years|
|Shelf life limited||●|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns||●|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Variety of sizes||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Non/Minimally Exudating Wounds
Change NEOX®FLO Wound Matrix as needed.
HTC/P human umbilical cord and amniotic membrane.
AMNIOX® Medical, Inc. is the first provider of a cryopreserved matrix comprised of both human umbilical cord and amniotic membrane allograft that can be stored in a refrigerator for up to two years and is ready to use without thawing, transplanting the benefits of regenerative healing for non-healing and chronic wounds.